Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEpisodic Src activation in uveal melanoma revealed by kinase activity profiling
British Journal of Cancer, 07/02/09
Maat W et al. - The authors identified Src as an important kinase and a potential target for treatment in primary UM. Metastasis cell lines seemed largely resistant to Src inhibition and indicate that in metastases treatment, a different approach may be required.
P A van der Velden, 07/02/09
| Tumor development is often driven by overactive kinases and these tumor promoters turn out to be good targets for treatment. Using kinase assays we could distinguish cell lines based on Src kinase activity and this correlated with efficacy of Src kinase inhibitor treatment. Measuring kinase activity in tumor specimen will assist to select the optimal therapy from a whole range of kinase inhibitors that are currently on the market. |
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09
Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study
Journal of Clinical Oncology, 10/29/09
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Sponsor
Article Search
Sponsor
Sponsor